Research Paper | Medicine Science | Albania | Volume 4 Issue 11, November 2015
Host Factors Influences on Treatment Response in Chronic Hepatitis C Patients Treated with pegINF and Ribavirin in Albania
Anila Kristo | Dr. Jovan Basho | Nikollaq Leka | Dr. Elizana Petrela | Jonila Cela
Abstract: Introduction The impact of viral factors like genotype, HCVRNA at baseline, or viral kinetics during treatment of chronic hepatitis C patients is better defined recently. In contrary different results comes from studies about the impact of age, gender or BMI on treatment response in chronic hepatitis C (CHC) with standard scheme. Aim To evaluate the predictive value of host factors (age, gender, BMI, biochemical and hematological profile) on treatment response in CHC patients in Albania. Patients and methods A total of 151patients, diagnosed with CHC in UHC Mother Tereza service of Gastro-Hepatology were included in this study. All the patients were treated with PegINF alfa-2a (180 g s. c/week) and ribavirin 800-1200 mg/day (according to body weight and genotype). The duration of treatment varied from 24-48 to72 weeks according to genotype and virological response. Patients were assessed for age, gender, BMI, TC (total cholesterol), TGC, Fast blood glucose (FBG), GGT, AST, ALT, WBC, PLT, HB and was evaluated their impact on treatment response in both SVR and Non-SVR group. Data were analyzed statistically by Chi square test and T test. P < 0.05 is considered significant. Results In general patients aged < 45 years/old had a SVR rates of 59.2 % and those - 45 years/old 64 % without significant differences between groups (Chi-square=0.366, df=1, p=0.545). Female patients had a SVR rate of 63.7 % and males 59.7 % (Chi-square =0.255, df=1, p=0.614) without significant differences between groups. The SVR rates of females < 45 years /old, females - 45 ys/old, males < 45 ys/old and males - 45 ys/old were respectively 66.7 %, 61.9 %, 55 %, 66.7 % in all cases without significant differences between groups. Through binary logistic regression technique, is shown that there is a causal link, statistically significant between the non-SVR and BMI - 27kg / m2, It can be said that patients with BMI> / = 27 kg / m2, are 2.6 times more likely than patients with BMI
Keywords: hepatitis C, host factors, treatment, impact
Edition: Volume 4 Issue 11, November 2015,
Pages: 2427 - 2434
How to Cite this Article?
Anila Kristo, Dr. Jovan Basho, Nikollaq Leka, Dr. Elizana Petrela, Jonila Cela, "Host Factors Influences on Treatment Response in Chronic Hepatitis C Patients Treated with pegINF and Ribavirin in Albania", International Journal of Science and Research (IJSR), Volume 4 Issue 11, November 2015, pp. 2427-2434, https://www.ijsr.net/get_abstract.php?paper_id=NOV151732
How to Share this Article?
Similar Articles with Keyword 'hepatitis C'
Additional Benefit of ?-Fetoprotein in Patients with Chronic Hepatitis B and C without Evidence of Hepatoma
Amino Acid Substitution in Hepatitis C Virus Core and Genetic Variation in Interleukin 28? Gene and their Correlation to Interferon Treatment Failure in Chronic HCV Egyptian Patients
Nashwa El-Khazragy  | Maiada A. Hussien | Mohamed A. El-Mordy | Amany M. Maher